GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sinco Pharmaceutical Holdings Ltd (HKSE:06833) » Definitions » Dividend Payout Ratio

Sinco Pharmaceutical Holdings (HKSE:06833) Dividend Payout Ratio : 0.27 (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sinco Pharmaceutical Holdings Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the months ended in Jun. 2024 was 0.27.

The historical rank and industry rank for Sinco Pharmaceutical Holdings's Dividend Payout Ratio or its related term are showing as below:

HKSE:06833' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.14   Med: 0.32   Max: 0.42
Current: 0.14


During the past 10 years, the highest Dividend Payout Ratio of Sinco Pharmaceutical Holdings was 0.42. The lowest was 0.14. And the median was 0.32.

HKSE:06833's Dividend Payout Ratio is ranked better than
85.25% of 61 companies
in the Medical Distribution industry
Industry Median: 0.41 vs HKSE:06833: 0.14

As of today (2025-04-01), the Dividend Yield % of Sinco Pharmaceutical Holdings is 2.00%.

During the past 10 years, the highest Trailing Annual Dividend Yield of Sinco Pharmaceutical Holdings was 5.78%. The lowest was 0.41%. And the median was 3.85%.

Sinco Pharmaceutical Holdings's Dividends per Share for the months ended in Jun. 2024 was HK$0.00.

During the past 12 months, Sinco Pharmaceutical Holdings's average Dividends Per Share Growth Rate was -60.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Sinco Pharmaceutical Holdings Dividend Payout Ratio Historical Data

The historical data trend for Sinco Pharmaceutical Holdings's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinco Pharmaceutical Holdings Dividend Payout Ratio Chart

Sinco Pharmaceutical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.42

Sinco Pharmaceutical Holdings Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.91 - 0.27

Competitive Comparison of Sinco Pharmaceutical Holdings's Dividend Payout Ratio

For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinco Pharmaceutical Holdings's Dividend Payout Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Sinco Pharmaceutical Holdings's Dividend Payout Ratio falls into.


;
;

Sinco Pharmaceutical Holdings Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0.01/ 0.024
=0.42

Sinco Pharmaceutical Holdings's Dividend Payout Ratio for the quarter that ended in Jun. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jun. 2024 )/ EPS without NRI (Q: Jun. 2024 )
=0.004/ 0.015
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinco Pharmaceutical Holdings (HKSE:06833) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Sinco Pharmaceutical Holdings Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Sinco Pharmaceutical Holdings's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinco Pharmaceutical Holdings Business Description

Traded in Other Exchanges
N/A
Address
No. 1700, North Section of Tianfu Avenue, E5-1805, Global Centre, High-Tech Zone, Chengdu, Sichuan Province, Chengdu, CHN
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
Executives
Huang Zhijian 2305 Beneficiary of a trust
Fullwealth Holdings Limited 2201 Interest of corporation controlled by you
Risun Investments Limited 2101 Beneficial owner
Wickhams Cay Trust Company Limited 2301 Trustee
Huang Xiangbin 2307 Founder of a discretionary trust who can infl

Sinco Pharmaceutical Holdings Headlines

No Headlines